We also have to talk about muscle mass
Preclinical studies in rodent models have consistently demonstrated that GLP-1 receptor agonists reduce voluntary alcohol intake and preference
Ong et al., Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021, The Lancet, vol
Financial and insurance assistance If you need financial support to pay for Synjardy, or if you need help understanding your insurance coverage, help is available
Most Synjardy 12.5 mg/1000 mg uses are tied to glycemic control, which means keeping blood glucose closer to the range set by a care team
Clinical studies show that patients typically lose 10-20% of their body weight over several months with GLP-1 therapy